Janus Genomics

Janus Genomics is developing a platform that allows training of algorithms on a combination of different biomedical datasets. The technology enables companies to monetize their data and keep it private. Janus Genomics has received support and was accelerated by Entrepreneurs First, Max Plank Intitute and University of Regensburg. 



One of the co-founders, Robin Röhm, was CEO of the company until December, 2018. Röhm is now CEO & Co-Founder at apheris AI.